GLP-1RA therapy significantly reduces the risk for new-onset heart failure in patients with type 2 diabetes or obesity, regardless of weight loss.

The FDA has granted breakthrough therapy designation (BTD) to sevabertinib (Hyrnuo, formerly BAY 2927088) for the first-line ...

In 2025, over 200 companies had their initial public offerings (IPOs) on U.S. exchanges. However, less than a quarter of ...

Incyte said on Monday its experimental combo therapy helped patients with a type of blood cancer live longer without their ...

AbbVie has delivered strong YTD outperformance, with shares up nearly 30% and robust analyst optimism, but I maintain a 'Hold ...

Capital is flocking to a few high-growth AI plays and ignoring other opportunities because of the AI trend in the markets.

Looking back, we can say that 2025 has been a milestone year for the healthcare industry. This year brought significant ...

Crime comedy series “High Potential” is a ratings powerhouse, attracting major buzz. The first season holds an impressive 98% approval on Rotten Tomatoes, while its second outdoes it comfortably, ...

Preordering any version of High on Life 2 gets you an exclusive "I pre-ordered High on Life 2" Visor in-game weapon skin that can be worn by the game's roster of talking alien armaments. Limited Run ...

Background High-flow nasal cannula (HFNC) therapy is increasingly used for lower respiratory tract infections (LRTIs) in infants and young children, but recommendations vary, and standardised practice ...

Our IGN First "cover story" game for December is High on Life 2, the upcoming comedy first-person shooter sequel to the 2022 original breakout hit from Squanch Games. We got our coverage warmed up ...